Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.07 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.09 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.5 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.5 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |